Lactulose: Clinical Trials

17 trials of Lactulose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 2 recruiting, 2 unknown, 1 terminated. 17 Phase 2, 6 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 217Completed 12, Recruiting 2, Unknown 2, Terminated 1
Phase 36Completed 4, Recruiting 1, Unknown 1
Phase 11Recruiting 1

Follow Lactulose: new trials by email Literature Review of Lactulose trials Research Report on Lactulose

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
Lactulose - Cancer
Phase 1 / Phase 2RecruitingUniversity of Chicago552026-12-152026-06-16
Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis
Clotrimazole+Lactulose., Canesten (Clotrimazole), Lactulose - Candidal Vulvovaginitis (ICD-10 Code: B37.3), Vulvovaginal Candidiasis (VVC)
Phase 2 / Phase 3RecruitingAVVA Pharmaceuticals Ltd.2642024-02-292025-02-19
Efficacy of Polyethylene Glycol vs Lactulose With Isabgol in Acute Fissure-in-Ano: PEGASIS Trial
Polyethylene Glycol, Isabgol + Lactulose - Anal Fissure, Constipation
Phase 2 / Phase 3CompletedAll India Institute of Medical Sciences, Bhubaneswar1442022-05-272023-07-25
A Trial to Improve Quality of Life in People With Cirrhosis
Lactulose - Cirrhosis
Phase 2 / Phase 3CompletedUniversity of Michigan562021-11-102023-11-21
Effect of Probiotic on Gut Microbiota in Young Children With Functional Constipation
Probiotic, Lactulose Oral Liquid Product, probiotic + lactulose - Functional Constipation in Children
Phase 2CompletedMin-Tze LIONG842020-06-102026-04-07
Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy
Nitazoxanide, Lactulose - Encephalopathy, Hepatic
Phase 2 / Phase 3UnknownSherief Abd-Elsalam1202016-01-012017-08-21
The Effects of Nitazoxanide in Hepatic Encephalopathy
Nitazoxanide, Oral lactulose, Metronidazole - Hepatic Encephalopathy
Phase 2UnknownAin Shams University362014-12-012015-01-08
A Pilot Study of Lactofiltrum to Treat Atopic Dermatitis in Adults
Lactofiltrum, Placebo - Atopic Dermatitis
Phase 2 / Phase 3CompletedAvva Rus, JSC902010-05-012010-09-14
Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life
VSL#3, Lactulose - Chronic Liver Disease, Hepatic Encephalopathy
Phase 2 / Phase 3CompletedCD Pharma India Pvt. Ltd.1202009-10-012013-06-04
Study of Lactulose in Children With Chronic Liver Disease
Lactulose, placebo - Minimal Hepatic Encephalopathy
Phase 2TerminatedIndiana University162009-01-012014-02-10
A Clinical Standardization Study of the Preferred Acupuncture Treatment Protocol to Treat Functional Constipation
deep needling, Lactulose, shallow needling - Constipation
Phase 2CompletedGuang'anmen Hospital of China Academy of Chinese Medical Sciences4752008-04-012014-06-04
Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy
AST-120, lactulose - Hepatic Encephalopathy
Phase 2CompletedOcera Therapeutics402007-09-012014-05-30
Lactulose Supplementation in Premature Infants
Lactulose, Dextrose - Necrotizing Enterocolitis, Sepsis
Phase 2CompletedBnai Zion Medical Center282005-02-012008-02-15
Movicol in Childhood Constipation (ProMotion Study)
Polyethylene glycol 3350 NA bicarbonate NaCl KCl (Movicol), Lactulose - Feces, Impacted
Phase 2CompletedNorgine602000-10-012007-01-04
Movicol in Childhood Constipation (ProMotion Study)
Polyethylene glycol 3350 NA bicarbonate NaCl KCl (Movicol), Lactulose - Chronic Constipation
Phase 2CompletedNorgine602000-10-012006-11-28
Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis
lactulose - Portal Hypertension, Hepatic Encephalopathy
Phase 2CompletedNational Center for Research Resources (NCRR)161994-11-012005-06-24
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
Etoposide, Rituximab, Prednisone - Diffuse Large B-Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma
Phase 2CompletedNational Cancer Institute (NCI)3481993-05-082025-06-22

Conditions studied

Hepatic Encephalopathy (6)  ·  Brain Diseases (2)  ·  Constipation (2)  ·  Fibrosis (2)  ·  Hypertension, Portal (2)  ·  Liver Diseases (2)  ·  Burkitt Lymphoma (1)  ·  Candidiasis, Vulvovaginal (1)  ·  Dermatitis, Atopic (1)  ·  Enterocolitis, Necrotizing (1)  ·  Fecal Impaction (1)  ·  Fissure in Ano (1)  ·  Gastrointestinal Diseases (1)  ·  Hypertension (1)  ·  Liver Failure (1)

Sponsors

Norgine (2)  ·  AVVA Pharmaceuticals Ltd. (1)  ·  Ain Shams University (1)  ·  All India Institute of Medical Sciences, Bhubaneswar (1)  ·  Avva Rus, JSC (1)  ·  Bnai Zion Medical Center (1)  ·  CD Pharma India Pvt. Ltd. (1)  ·  Guang'anmen Hospital of China Academy of Chinese Medical Sciences (1)  ·  Indiana University (1)  ·  Min-Tze LIONG (1)  ·  National Cancer Institute (NCI) (1)  ·  National Center for Research Resources (NCRR) (1)  ·  Ocera Therapeutics (1)  ·  Sherief Abd-Elsalam (1)  ·  University of Chicago (1)

Countries

United States (5)  ·  China (2)  ·  Egypt (2)  ·  India (2)  ·  Russia (2)  ·  United Kingdom (2)  ·  Belarus (1)  ·  Israel (1)  ·  Malaysia (1)

Top investigators

David CA Candy, MD (2)  ·  Andres Blei (1)  ·  Arieh Riskin, MD (1)  ·  Asem Elfert, Prof (1)  ·  Asmaa A. Elrakaybi, Bachelor (1)  ·  Daniel Olson (1)  ·  Elliot Tapper, MD (1)  ·  Girish Subbarao, M.D. (1)  ·  Lyudmila Kobeleva, MD, PhD (1)  ·  Mark J Roschewski, M.D. (1)  ·  Mennat-Allah Elsawaf, lecturer (1)  ·  Nickolay A. Kryuchkov, MD, PhD, MPH (1)  ·  Paul Pockros, MD (1)  ·  Prakash Kumar Sasmal, MBBS, MS (1)

Results publications

PMID 16819379, PMID 23574119, PMID 24224624, PMID 25024303, PMID 25526462, PMID 29748435, PMID 30125215, PMID 34432874, PMID 35882475